Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Oligopin on Polycystic Ovary Syndrome (PCOS)
IRCT20140406017139N3Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of french maritime pine bark extract in polycystic ovary syndrome (PCOS), sponsored by Alborz University of Medical Sciences. Started Oct 2018; status: completed.
02
Drugs
french maritime pine bark extract
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20140406017139N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140406017139N3.